Cardiovascular-kidney-metabolic (CKM)-related mortality rates are disproportionately high in rural areas compared with large ...

A study was conducted to determine the relationship between health care utilization and cardiovascular complication ...

Among US adults without diabetes, the use of GLP-1 RAs increased from 2018 to 2022, reaching annual prevalence of 0.4% in 2022.

HealthDay News — Relaxation and stress management techniques have short-term beneficial effects for people with hypertension, according to a systematic review and network meta-analysis published ...

Exposure-response curves reveal the impacts of daytime-only, nighttime-only, and compound heatwaves on cause-specific heart disease mortality.

Female sex, number of comorbidities, and acute illness severity were risk factors for long COVID among adults with COVID-19 infection during the pre-Delta variant period.

SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.

Physician women had higher suicide rates compared to the general population from 2017 to 2021, though statistical significance remains unclear.

The FDA has updated the labeling for Camzyos to reduce echocardiogram monitoring requirements for patients in the maintenance phase and contraindications.

Patients with infection-related hospitalization may have increased risk for incident heart failure, including HFrEF and HFpEF.

Topline data were announced from a phase 3 trial evaluating orforglipron in adults with T2D and inadequate glycemic control with diet and exercise alone.

Polypharmacy is associated with poor clinical outcomes following COVID-19 infection among patients with type 2 diabetes.